The CEO highlighted the challenge of measuring revenue recurrence due to previous supply constraints and customer churn calculations.
Amy Li, Jefferies: Asked about the path to $1 billion in 2027 and visibility into the patient funnel. Kaseta explained the market opportunity and expanding share, adding, "We feel very bullish in our ...
The offseason is in full swing and the Dallas Cowboys are in the process of determining what they want to do with many of ...
More than 100 jobs are at risk at a major UK supermarket chain as it launches a major overhaul of its operations.
The Texas Rangers didn’t make a loud move this spring, but they made a meaningful one. Andrew McCutchen, a former National ...
As free agency and the draft near, nine teams have a huge question mark at quarterback. We have answers.
Ranking the 110 best available players in NFL free agency, with updates and analysis for everyone on the market.
Late-breaking oral presentation to feature primary analysis from KYSA-8 registrational trial in stiff person syndrome (SPS) ...
PHILIPPINE BANKS’ profit growth could slow down this year as the interest rate environment normalizes and with geopolitical risks adding more uncertainty to already gloomy economic prospects.
She also underscores MSMEs as the missing link in India’s growth story, pointing to digital public infrastructure such as the ...
Resident Evil 1 remake rumors are back, with a report claiming Capcom has started production and the project could take years ...
ImmunityBio (NASDAQ: IBRX) is a mid-cap drugmaker making waves in this niche right now; the company's shares have soared over the last 12 months. Although ImmunityBio appears promising, investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results